Literature DB >> 17105389

VEGF gene and phenotype relation with Alzheimer's disease and mild cognitive impairment.

Martina Chiappelli1, Barbara Borroni, Silvana Archetti, Elena Calabrese, Massimiliano M Corsi, Massimo Franceschi, Alessandro Padovani, Federico Licastro.   

Abstract

BACKGROUND: The expression of vascular endothelial growth factor (VEGF) represents one potential mechanism whereby vascular and Alzheimer's disease (AD) pathologies are related. The authors investigated whether AD cases, especially those having a rapid cognitive decline, more commonly carried a functional promoter gene variant for VEGF (-2578C/A) and showed elevated plasma levels of Vegf. In addition, the authors investigated whether patterns of association also were found for mild cognitive impairment (MCI) and conversion from MCI to AD.
METHODS: Group 1 included 317 AD cases and 320 unaffected control subjects. Group 2 included 113 MCI patients and 130 control subjects. Plasma levels of Vegf were measured by chemiluminescence for a subset of group 1. Genotype determinations were made for all subjects.
FINDINGS: The VEGF AA genotype was associated with an increased risk of developing AD (OR = 1.616, p = 0.046). This genotype also was associated with an accelerated cognitive decline in APOE small epsilon4 positive patients with AD (AA vs. CC OR = 6.5, p = 0.04). The VEGF AA genotype was a risk factor for MCI (OR = 2.5, p = 0.037) and MCI conversion to AD in APOE small epsilon4+ (OR = 6.5, CI = 2.014-20.980; p = 0.002). Vegf plasma levels were higher in patients with AD than controls (230 pg/mL vs. 42 pg/mL), and were even higher in those patients with a fast cognitive decline and the APOE epsilon4 allele.
INTERPRETATION: Modulation of VEGF expression is a potential mechanism associated with the risk of developing AD and its clinical deterioration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17105389     DOI: 10.1089/rej.2006.9.485

Source DB:  PubMed          Journal:  Rejuvenation Res        ISSN: 1549-1684            Impact factor:   4.663


  35 in total

1.  Relationship between vitamin D receptor gene polymorphism and mild cognitive impairment in elderly Uygur people.

Authors:  Kabinuer Keyimu; Xiao-Hui Zhou; Hai-Jun Miao; Ting Zou
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Postmortem Brain, Cerebrospinal Fluid, and Blood Neurotrophic Factor Levels in Alzheimer's Disease: A Systematic Review and Meta-Analysis.

Authors:  Yang Du; Huan-Tong Wu; Xiao-Yan Qin; Chang Cao; Yi Liu; Zong-Ze Cao; Yong Cheng
Journal:  J Mol Neurosci       Date:  2018-06-28       Impact factor: 3.444

3.  No association of VEGF polymorphims with Alzheimer's disease.

Authors:  Sara Landgren; Mona Seibt Palmér; Ingemar Skoog; Lennart Minthon; Anders Wallin; Niels Andreasen; Madeleine Zetterberg; Kaj Blennow; Henrik Zetterberg
Journal:  Neuromolecular Med       Date:  2009-10-20       Impact factor: 3.843

4.  Structured Sparse Kernel Learning for Imaging Genetics Based Alzheimer's Disease Diagnosis.

Authors:  Jailin Peng; Le An; Xiaofeng Zhu; Yan Jin; Dinggang Shen
Journal:  Med Image Comput Comput Assist Interv       Date:  2016-10-02

5.  Age-related vascular pathology in transgenic mice expressing presenilin 1-associated familial Alzheimer's disease mutations.

Authors:  Miguel A Gama Sosa; Rita De Gasperi; Anne B Rocher; Athena Ching-Jung Wang; William G M Janssen; Tony Flores; Gissel M Perez; James Schmeidler; Dara L Dickstein; Patrick R Hof; Gregory A Elder
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

Review 6.  Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.

Authors:  D Allan Butterfield; Tanea Reed; Shelley F Newman; Rukhsana Sultana
Journal:  Free Radic Biol Med       Date:  2007-06-13       Impact factor: 7.376

Review 7.  Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

8.  APOE ε4-specific associations of VEGF gene family expression with cognitive aging and Alzheimer's disease.

Authors:  Annah M Moore; Emily Mahoney; Logan Dumitrescu; Philip L De Jager; Mary Ellen I Koran; Vladislav A Petyuk; Renã As Robinson; Douglas M Ruderfer; Nancy J Cox; Julie A Schneider; David A Bennett; Angela L Jefferson; Timothy J Hohman
Journal:  Neurobiol Aging       Date:  2019-11-05       Impact factor: 4.673

9.  Ameliorative Effects of α-Tocopherol and/or Coenzyme Q10 on Phenytoin-Induced Cognitive Impairment in Rats: Role of VEGF and BDNF-TrkB-CREB Pathway.

Authors:  Marwa M Nagib; Mariane G Tadros; Rania M Rahmo; Nagwa Ali Sabri; Amani E Khalifa; Somaia I Masoud
Journal:  Neurotox Res       Date:  2018-10-29       Impact factor: 3.911

Review 10.  Vascular endothelial growth factor gene promoter polymorphisms and Alzheimer's disease risk: a meta-analysis.

Authors:  Sheng-Yuan Liu; Fang-Fang Zeng; Zhong-Wei Chen; Chang-Yi Wang; Bin Zhao; Ke-Shen Li
Journal:  CNS Neurosci Ther       Date:  2013-04-10       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.